Skip to main content

Table 5 The correlations between the clinicopathological factors and numbers of lymphocyte subsets, pre- and post- CRT

From: Prediction of the preoperative chemoradiotherapy response for rectal cancer by peripheral blood lymphocyte subsets

Gender

Pre-CRT

Post-CRT

 

Male

Female

P value

Male

Female

P value

T lymphocytes

1,196 (675 − 2,273)

1,046 (686 − 1,688)

0.325

608 (258 − 1,240)

455 (321 − 1,856)

0.228

Th lymphocytes

667 (329 − 1,489)

587 (383 − 1,180)

0.619

248 (89 − 696)

196 (118 − 692)

0.334

Tc lymphocytes

448 (258 − 855)

374 (200 − 847)

0.083

324 (119 − 671)

238 (137 − 1,144)

0.441

B lymphocytes

140 (31 − 675)

173 (30 − 409)

0.822

40 (1 − 185)

20 (9 − 73)

0.026

Natural killer cells

259 (56 − 966)

236 (135 − 1,020)

0.831

179 (15 − 811)

162 (35 − 497)

0.519

Depth of invasion

Pre-CRT

Post-CRT

 

pT0-2

pT3/4

P value

pT0-2

pT3/4

P value

T lymphocytes

1,196 (732 − 2,217)

1,157 (675 − 2,273)

0.489

482 (258 − 1,010)

694 (268 − 1,856)

0.136

Th lymphocytes

683 (329 − 1,496)

513 (361 − 1,364)

0.525

215 (89 − 620)

276 (99 − 696)

0.120

Tc lymphocytes

458 (200 − 847)

394 (270 − 855)

0.658

268 (141 − 495)

348 (119 − 1,144)

0.182

B lymphocytes

172 (73 − 675)

143 (30 − 459)

0.594

31 (1 − 140)

24 (9 − 185)

0.619

Natural killer cells

221 (135 − 966)

268 (56 − 1,020)

0.586

167 (28 − 335)

179 (15 − 811)

0.261

Lymph node metastasis

Pre-CRT

Post-CRT

 

Absent

Present

P value

Absent

Present

P value

T lymphocytes 1,135

(675 − 2,273) 1,233

(686 − 1,399)

0.507

494 (268 − 1,856)

628 (258 − 1,240)

0.332

Th lymphocytes

665 (329 − 1,496)

641 (383 − 907)

0.395

217 (99 − 696)

276 (89 − 564)

0.346

Tc lymphocytes

430 (258 − 855)

439 (200 − 752)

0.970

307 (119 − 1144)

316 (167 − 671)

0.324

B lymphocytes

178 (77 − 675)

122 (30 − 459)

0.089

26.5 (9 − 185)

30 (1 − 94)

0.769

Natural killer cells

260 (56 − 929)

232 (124 − 1,020)

0.590

173.5 (15 − 811)

174 (45 − 552)

0.837

Lymphatic invasion

Pre-CRT

Post-CRT

 

Absent

Present

P value

Absent

Present

P value

T lymphocytes

1,181 (732 − 2,273)

895 (675 − 2,217)

0.247

494 (258 − 1,856) 694

(366 − 1,240)

0.136

Th lymphocytes

675 (329 − 1,364)

602 (361 − 1,496)

0.491

210 (89 − 696)

276 (226 − 564)

0.100

Tc lymphocytes

453 (258 − 855)

350 (200 − 694)

0.434

268 (137 − 1,144)

348 (119 − 671)

0.206

B lymphocytes

167 (30 − 675)

122 (33 − 185)

0.103

27 (1 − 185)

30 (10 − 70)

0.931

Natural killer cells

232 (56 − 1,020)

495 (135 − 929)

0.199

167 (28 − 811)

201 (15 − 552)

0.283

Venous invasion

Pre-CRT

Post-CRT

 

Absent

Present

P value

Absent

Present

P value

T lymphocytes

1,122 (675 − 2,273)

1,181 (686 − 2,217)

0.774

481 (328 − 1,200)

619 (258 − 1,856)

0.227

Th lymphocytes

722 (329 − 1,364)

607 (383 − 1,496)

0.505

224 (146 − 696)

265 (89 − 692)

0.896

Tc lymphocytes

371 (200 − 855)

464 (258 − 847)

0.228

233 (119 − 495)

321 (137 − 1,144)

0.112

B lymphocytes

193 (73 − 409)

137 (30 − 675)

0.370

29 (10 − 185)

25 (1 − 121)

0.520

Natural killer cells

210 (117 − 498)

314 (56 − 1,020)

0.024

132 (15 − 811)

201 (80 − 552)

0.018

  1. Data are expressed as median (range).
  2. Pre-CRT: measured before chemoradiation therapy; post-CRT: measured after chemoradiation therapy.